Hwang Jiann-Loung, Seow Kok-Min, Lin Yu-Hung, Hsieh Bih-Chwen, Huang Lee-Wen, Chen Heng-Ju, Huang Shih-Chia, Chen Chin-Yu, Chen Pei-Hsin, Tzeng Chii-Ruey
Department of Obstetrics and Gynecology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Hum Reprod. 2005 May;20(5):1261-5. doi: 10.1093/humrep/deh786. Epub 2005 Feb 10.
This study compares the fertilization rate and embryonic development of oocytes randomly inseminated by conventional IVF or ICSI in patients with polycystic ovarian syndrome (PCOS) and normozoospermic semen during IVF cycles.
Sibling oocytes were randomized to be inseminated either by ICSI or IVF. Fertilization rate (two pronuclei/COC), day 2 embryonic morphology and rate of development were assessed.
A total of 1089 cumulus-oocyte complexes (COC) were collected in 60 cycles (mean+/-SD, 18.2 +/- 7.2). Totals of 541 and 548 COC were inseminated by IVF and ICSI respectively, with a significantly higher fertilization rate in the ICSI group (ICSI versus IVF, 72.3 +/- 15.5 versus 44.8 +/- 25.1%). No fertilization failure occurred in the group of oocytes inseminated by ICSI, whereas the COC in nine patients (15%) inseminated by IVF had complete fertilization failure. The day 2 embryonic morphology and rate of development were not different regardless of the insemination method.
Our results suggested that another randomized controlled study, randomizing patients instead of sibling oocytes, should be undertaken to compare the pregnancy rate per started cycle and to see whether ICSI should be performed on all, or at least on a portion of, oocytes for patients with PCOS undergoing IVF cycles.
本研究比较了多囊卵巢综合征(PCOS)患者在体外受精(IVF)周期中,使用常规IVF或卵胞浆内单精子注射(ICSI)随机授精的卵母细胞的受精率和胚胎发育情况,精液为正常精子。
将同胞卵母细胞随机分为ICSI或IVF授精组。评估受精率(双原核/卵丘-卵母细胞复合体)、第2天胚胎形态和发育率。
在60个周期中共收集了1089个卵丘-卵母细胞复合体(COC)(均值±标准差,18.2±7.2)。分别有541个和548个COC进行了IVF和ICSI授精,ICSI组的受精率显著更高(ICSI与IVF相比,72.3±15.5对44.8±25.1%)。ICSI授精的卵母细胞组未发生受精失败,而9例(15%)IVF授精患者的COC发生了完全受精失败。无论授精方法如何,第2天的胚胎形态和发育率均无差异。
我们的结果表明,应进行另一项随机对照研究,将患者而非同胞卵母细胞随机分组,以比较每个启动周期的妊娠率,并确定对于接受IVF周期的PCOS患者,是否应对所有或至少部分卵母细胞进行ICSI。